Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Cheng Shen

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|November 27, 2021
Advances in Diagnostic BronchoscopyYi-Cheng Shen, Chia-Hung Chen, Chih-Yen Tu
Acta Crystallographica. Section C, Crystal Structure Communications|April 7, 2007
Poly[mu2-trans-1,2-di-4-pyridylethylene-kappa2N:N'-mu2-sulfato-kappa2O:O'-zinc(II)]Yi Cheng Shen, Zhao Ji Li, Ye Yan Qin, et al.
Thoracic Cancer|August 9, 2020
Etiologies of delayed diagnosis and six-month outcome of patients with newly diagnosed advanced lung cancer with respiratory failure at initial presentationHow-Yang Tseng, Yi-Cheng Shen, Yen-Sung Lin, et al.
Journal of Global Antimicrobial Resistance|June 16, 2023
Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trialsMeng-Hsuan Lin, Yi-Cheng Shen, Han-Yun Cheng, et al.
Thoracic Cancer|April 8, 2022
The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from TaiwanWen-Chien Cheng, Yi-Cheng Shen, Chun-Ru Chien, et al.
Diagnostics (Basel, Switzerland)|January 8, 2023
The Feasibility of Interventional Pulmonology Methods for Detecting the T790M Mutation after the First or Second-Generation EGFR-TKI Resistance of Non-Small Cell Lung CancerWen-Chien Cheng, Yi-Cheng Shen, Chieh-Lung Chen, et al.
Cancers|February 11, 2023
Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational StudyWen-Chien Cheng, Yi-Cheng Shen, Chieh-Lung Chen, et al.
Anticancer Research|February 27, 2022
Association of <i>Interleukin-8</i> Promoter Genotypes With Taiwan Lung Cancer RiskChia-Hsiang Li, Ya-Chen Yang, Te-Chun Hsia, et al.
Anticancer Research|November 4, 2021
Association of <i>TIMP-2</i> Rs8179090 Genotypes With Lung Cancer Risk in TaiwanWei-Chih Liao, Chien-Wen Huang, Te-Chun Hsia, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutationsYi-Cheng Shen, Guan-Chin Tseng, Chih-Yeh Tu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|November 27, 2021
Advances in Diagnostic BronchoscopyYi-Cheng Shen, Chia-Hung Chen, Chih-Yen Tu
Acta Crystallographica. Section C, Crystal Structure Communications|April 7, 2007
Poly[mu2-trans-1,2-di-4-pyridylethylene-kappa2N:N'-mu2-sulfato-kappa2O:O'-zinc(II)]Yi Cheng Shen, Zhao Ji Li, Ye Yan Qin, et al.
Thoracic Cancer|August 9, 2020
Etiologies of delayed diagnosis and six-month outcome of patients with newly diagnosed advanced lung cancer with respiratory failure at initial presentationHow-Yang Tseng, Yi-Cheng Shen, Yen-Sung Lin, et al.
Journal of Global Antimicrobial Resistance|June 16, 2023
Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trialsMeng-Hsuan Lin, Yi-Cheng Shen, Han-Yun Cheng, et al.
Thoracic Cancer|April 8, 2022
The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from TaiwanWen-Chien Cheng, Yi-Cheng Shen, Chun-Ru Chien, et al.
Diagnostics (Basel, Switzerland)|January 8, 2023
The Feasibility of Interventional Pulmonology Methods for Detecting the T790M Mutation after the First or Second-Generation EGFR-TKI Resistance of Non-Small Cell Lung CancerWen-Chien Cheng, Yi-Cheng Shen, Chieh-Lung Chen, et al.
Cancers|February 11, 2023
Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational StudyWen-Chien Cheng, Yi-Cheng Shen, Chieh-Lung Chen, et al.
Anticancer Research|February 27, 2022
Association of <i>Interleukin-8</i> Promoter Genotypes With Taiwan Lung Cancer RiskChia-Hsiang Li, Ya-Chen Yang, Te-Chun Hsia, et al.
Anticancer Research|November 4, 2021
Association of <i>TIMP-2</i> Rs8179090 Genotypes With Lung Cancer Risk in TaiwanWei-Chih Liao, Chien-Wen Huang, Te-Chun Hsia, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutationsYi-Cheng Shen, Guan-Chin Tseng, Chih-Yeh Tu, et al.
Pageof 3